title: 3.4 kb mitochondrial genome deletion serves as a surrogate predictive biomarker for prostate cancer in histopathologically benign biopsy cores.
authors.affiliation: Genesis Genomics Inc., Thunder Bay, ON;
authors.forename: Brian
authors.initials: B
authors.lastname: Reguly
authors.forename: John P
authors.initials: JP
authors.lastname: Jakupciak
authors.forename: Ryan L
authors.initials: RL
authors.lastname: Parr